Bausch Health Cos. may kick off a new debt offering in the coming weeks as it explores options to refinance near-term liabilities, according to people with knowledge of the matter.
The pharmaceutical company is considering a deal of about $5 billion, although the size and structure are still under discussion, and plans may change, said the people, who asked not to be identified because the talks are private.
Bausch Health said on its earnings call earlier this month that it was planning to tap the capital markets in the first half of the year to address near-dated maturities and that ...
